Nevada lawmakers have approved a revised bill that would create a new working group to study psychedelics and develop a plan to allow regulated access for therapeutic purposes.
While the legislation before the Senate Health and Human Services Committee as introduced would have legalized psilocybin and promoted research into the psychedelic, as well as encouraged studies of MDMA, the panel adopted an amendment that scales it back significantly.
As approved in a voice vote on Thursday, Sen. Rochelle Nguyen’s (D) measure now focuses on forming a Psychedelic Medicines Working Group to examine the use of entheogens “in medicinal, therapeutic, and improved wellness.”
The sponsor had acknowledged that the legislation would likely be significantly amended during a hearing in the same panel last month, stating that she would be amenable to changes and primarily wanted to initiate a conversation in the legislature about psychedelics reform.
“It was amazing how many people this bill has touched—people that have not participated in the political process, people whose lives they credit from these medicines and these therapies,” Nguyen said ahead of the vote on Thursday. “I look forward to what comes out of this bill and what comes out of the research and the
Read full article on Marijuana Moment
